Previous study has shown that SETD2-mutant leukemia exhibits reduced phosphorylated ATR, indicating impaired DDR [6]; however, the efficacy of ATM/ATR-i in SETD2-mutant leukemia remains unknown. The gene discussed is ATM; the disease is leukemia.